CARsgen Appoints Dr. Sylvie Peltier as Senior Vice President of Global Regulatory Affairs
- Written by PR Newswire
SHANGHAI, Oct. 31, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that Dr. Sylvie Peltier ("Dr. Peltier") has been appointed as Senior Vice President of Global Regulatory Affairs of the...
Read more: CARsgen Appoints Dr. Sylvie Peltier as Senior Vice President of Global Regulatory Affairs